Acetazolamide vasoreactivity in vascular dementia: A positron emission tomographic study

Citation
J. De Reuck et al., Acetazolamide vasoreactivity in vascular dementia: A positron emission tomographic study, EUR NEUROL, 41(1), 1999, pp. 31-36
Citations number
42
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
EUROPEAN NEUROLOGY
ISSN journal
00143022 → ACNP
Volume
41
Issue
1
Year of publication
1999
Pages
31 - 36
Database
ISI
SICI code
0014-3022(1999)41:1<31:AVIVDA>2.0.ZU;2-G
Abstract
The present study investigates the vasoreactivity of the brain in patients with large infarcts and dementia (multiinfarct dementia; MID) and in patien ts with microangiopathy, lacunes, white matter changes a nd dementia (lacun ar dementia; LD) using positron emission tomography (PET) and (NH3)-N-13 as regional cerebral blood flow (rCBF) tracer. In the control group, an incre ase in rCBF ranging from 32 to 43% was found in all brain regions after int ravenous acetazolamide administration. In both the MID group and the group with multiple infarcts without dementia, moderate loss of vasoreactivity wa s observed in the frontal, temporal and parietal cortex compared to the con trol values. Vasoreactivity was severely impaired in all cerebral regions o f the LD group and restricted to the thalamus in the group with lacunes and white matter changes without dementia (lacunar stroke; LS), This suggests that global loss of vasoreactivity is not a determining factor in the occur rence of MID, but might be important in LD, The present study shows that lo ss of the vascular reserve leading to exhausted metabolic reserve of the wh ole brain is one of the possible mechanisms for the occurrence of vascular dementia.